SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

Share Price is delayed by 15 minutes
Get Live Data
129.00    0.00 (0.00%)
Bid:
127.00
Ask:
131.00
Spread: 4.00 (3.15%)
Market Cap: £1.18b
NBS Live PriceLast checked at - London Stock Exchange

Intraday Nationwide Ccds Share Chart

Stabilisation Notice

7 Sep 2017 09:34

RNS Number : 0984Q
J.P. Morgan Securities PLC.
07 September 2017
 

07th September 2017

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Nationwide Building Society ("Nationwide")

Pre-stabilisation Period Announcement

J.P. Morgan Securities plc, (contact: Emma Lovett 0207 134 2468) hereby gives notice, as Stabilisation Coordinator, that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/2016/1052 under the Market Abuse Regulation (EU/596/2014).

The securities:

Issuer:

Nationwide Building Society ("Nationwide")

Guarantor (if any):

N/A

Aggregate nominal amount:

£ TBC Core Capital Deferred Shares

 

Description:

Tap of Core Capital Deferred Shares ("CCDS") 10.25% Perp

 

Offer price:

TBC

Other offer terms:

Immediately fungible on ISIN- GB00BBQ33664

Stabilisation:

Stabilisation Manager(s):

J.P. Morgan Securities plc (Stabilisation coordinator)

Merrill Lynch International (Stabilisation Manager)

Barclays Bank PLC (Stabilisation Manager)

Citigroup Global Capital Markets Limited (Stabilisation Manager)

UBS Limited (Stabilisation Manager)

Stabilisation period expected to start on:

7h September 2017

Stabilisation period expected to end no later than:

8th October 2017

Existence, maximum size and conditions of use of overallotment facility:

In connection with its stabilising activities Nationwide has granted J.P. Morgan, on behalf of the underwriters, an over-allotment option, exercisable, in whole or in part, at any time during the period commencing after the announcement of the Offer Price and ending on the business day falling immediately prior to the publication of the Prospectus, which if exercised, will require Nationwide to issue up to 15 per cent. of the aggregate number of CCDS available in the Offer (before any exercise of the Over-allotment Option) at the Offer Price to cover short positions arising from such over-allotments (if any) and/or sales of CCDS effected by it during the stabilising period.

J.P. Morgan has agreed with Nationwide that any over-allotment of CCDS by it or any of its agents will be up to a maximum of 15 per cent. of the total number of CCDS comprised in the Offer (before any exercise of the Over-allotment Option).

Stabilisation trading venue:

Over the counter, TBC

 

In connection with the offer of the above securities, the Stabilising Manager(s), or persons acting on behalf of the Stabilising Manager(s) may over-allot the securities or effect other transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time, but it must end no later than the day falling 30 calender days after the date of allotment of the securities.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that in that Member State

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAEAPNXEDFXEEF
Date   Source Headline
17th Aug 20235:49 pmRNSPublication of Final Terms
16th Aug 20234:43 pmRNSPublication of Final Terms
14th Aug 20234:19 pmRNSPublication of Final Terms
10th Aug 20233:23 pmRNSPublication of Final Terms
8th Aug 20234:15 pmRNSPublication of Final Terms
28th Jul 202312:24 pmRNSPublication of Final Terms
19th Jul 20233:26 pmRNSResult of AGM
18th Jul 202312:55 pmRNSPublication of Final Terms
12th Jul 20239:49 amRNSPublication of Final Terms
12th Jul 20237:30 amRNSResponse to Results of BoE Stress Test 2022
11th Jul 20237:00 amRNSPublication of Final Terms
11th Jul 20237:00 amRNSPublication of Final Terms
3rd Jul 20231:08 pmRNSRedemption of Notes
30th Jun 20232:35 pmRNSPublication of Final Terms
28th Jun 20233:53 pmRNSTender Offer
26th Jun 202311:57 amRNSPublication of a Prospectus
26th Jun 202310:35 amRNSTender Offer
8th Jun 20233:21 pmRNSPublication of Final Terms
5th Jun 20236:14 pmRNSPublication of Final Terms
5th Jun 20235:28 pmRNSPublication of Final Terms
26th May 20237:00 amRNSDirectorate Change
19th May 202312:24 pmRNSPublication of Suppl.Prospcts
19th May 20237:00 amRNSAnnual Financial Report
12th Apr 20238:24 amRNSPost Stabilisation Notice - Nationwide
15th Mar 20235:43 pmRNSPublication of Final Terms
8th Mar 20238:35 amRNSPre-Stabilisation Notice - Nationwide
23rd Feb 20233:43 pmRNSResult of Tender Offer
22nd Feb 20233:36 pmRNSTender Offer
20th Feb 202311:10 amRNSTender Offer - Initial OMR Announcement
9th Feb 202311:08 amRNSAmendments to certain Covered Bond Swap Agreements
23rd Jan 20235:04 pmRNSPublication of Final Terms
20th Jan 20231:47 pmRNSPublication of Final Terms
18th Jan 202310:03 amRNSPublication of Final Terms
13th Jan 202310:52 amRNSRedemption of Notes
14th Dec 20224:10 pmRNSPublication of Suppl.Prospcts
14th Dec 20223:18 pmRNSPublication of Suppl.Prospcts
13th Dec 20221:50 pmRNSPublication of Final Terms
5th Dec 20226:06 pmRNSPublication of Final Terms
30th Nov 202211:34 amRNSTender Offer Results for certain Silverstone Notes
22nd Nov 20228:59 amRNSTender Offer Notice for certain Silverstone Notes
18th Nov 20223:10 pmRNSPublication of Supplemental Prospectus
18th Nov 20227:00 amRNSHalf-year Report
24th Oct 20224:05 pmRNSPublication of a Prospectus
28th Sep 20227:00 amRNSDirectorate Change
22nd Sep 20223:29 pmRNSPublication of Final Terms
20th Sep 20229:52 amRNSPublication of Final Terms
12th Sep 20226:10 pmRNSPublication of a Prospectus
2nd Sep 20223:26 pmRNSPublication of Final Terms
2nd Sep 202212:13 pmRNSPublication of Final Terms
30th Aug 20221:07 pmRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.